STOCK TITAN

Hercules Capital Inc - HTGC STOCK NEWS

Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.

Hercules Capital, Inc. (NYSE: HTGC) is a premier specialty finance company dedicated to providing senior secured loans to high-growth, venture capital-backed companies in technology-related markets. Established in December 2003, Hercules has positioned itself as a key player in the venture lending space, committing over $4.6 billion to more than 300 companies across various stages of development. The company focuses on sectors such as technology, biotechnology, life sciences, and sustainable and renewable energy.

Hercules Capital stands out by offering more than just financial support. The company provides vital access to its expansive network of contacts and invaluable business advice, helping entrepreneurial companies achieve significant milestones. Their investment portfolio includes a mix of structured debt with warrants, senior debt, and equity investments.

Recent achievements include a $35 million loan facility to SynOx Therapeutics Limited to support the development of emactuzumab, a next-generation monoclonal antibody for treating Tenosynovial Giant Cell Tumour (TGCT). Another notable investment is the $150 million financing to Harness, a Modern Software Delivery Platform company, to expand its platform with new modules and enhance its use of generative AI.

Hercules Capital’s strategic partnerships and financial solutions make it the lender of choice for venture-backed companies seeking reliable growth capital. The company’s financial stability and extensive industry expertise ensure that it remains a trusted partner for innovation-driven businesses looking to scale.

Rhea-AI Summary
Hercules Capital, Inc. (HTGC) plans to make a public offering of 6,000,000 shares of its common stock, with an option to purchase up to an additional 900,000 shares. The net proceeds will be used for investments in debt and equity securities, repayment of indebtedness, and general corporate purposes. The offering is made pursuant to an effective shelf registration statement filed with the SEC on December 17, 2021.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
-
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) announced its financial results for Q2 2023. Total investment income increased by 61.2% YoY to $116.2 million. Net investment income (NII) was $75.7 million, or $0.53 per share, an 88.6% YoY increase. Total gross fundings for 1H 2023 reached $834.8 million, a 5.6% YoY increase. The company increased its base cash distribution to $0.40 per share, with Q2 2023 NII providing 132% coverage. Undistributed earnings spillover amounted to $148.1 million, or $1.02 per share. Assets under management increased by 19.5% YoY to approximately $4.0 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.92%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
Rhea-AI Summary
Heron Therapeutics, Inc. has entered into a securities purchase agreement to sell 20,734,917 shares of its common stock and pre-funded warrants to institutional investors. The purchase price for the common stock is $1.37 per share, while the pre-funded warrants have a purchase price of $1.3699 per warrant. The gross proceeds from the private placement are expected to be approximately $30.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
none
-
Rhea-AI Summary
Hercules Capital, Inc. has scheduled its second quarter 2023 financial results conference call for August 3, 2023, at 2:00 p.m. PT. The company will release its financial results after market close on the same day. A live webcast of the conference call will be available on the investor relations section of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
-
Rhea-AI Summary
Hercules Capital, Inc. reported record Q1 2023 total gross fundings of $476.2 million, total investment income of $105.1 million (up 61.3% YoY), and net investment income (NII) of $65.5 million (up 83.0% YoY). Q1 2023 NII provides 123% coverage of the base cash distribution. Hercules had approximately $1.0 billion of available liquidity at the end of the quarter. The company also established a new institutional private credit lending program and saw a 33.2% increase in assets under management to over $3.9 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.47%
Tags
-
Rhea-AI Summary
Hercules Capital, Inc. announces a first quarter 2023 total cash distribution of $0.47 per share. The distribution is comprised of a $0.39 per share base distribution and an $0.08 per share supplemental distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
none
Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) has scheduled its first quarter 2023 financial results conference call for May 4, 2023, at 2:00 p.m. PT (5:00 p.m. ET). The financial results will be released after market close on the same day. Interested participants can register here for telephone access, or join the live webcast via the investor relations section on Hercules’ website at investor.htgc.com. Hercules Capital specializes in providing senior secured venture growth loans and has committed over $16 billion to more than 600 companies since its inception in December 2003.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags

FAQ

What is the current stock price of Hercules Capital (HTGC)?

The current stock price of Hercules Capital (HTGC) is $21.47 as of February 21, 2025.

What is the market cap of Hercules Capital (HTGC)?

The market cap of Hercules Capital (HTGC) is approximately 3.8B.

What does Hercules Capital, Inc. specialize in?

Hercules Capital specializes in providing senior secured loans to venture capital-backed companies in technology-related industries.

Which industries does Hercules Capital, Inc. focus on?

Hercules Capital focuses on technology, biotechnology, life sciences, and sustainable and renewable energy sectors.

How much has Hercules Capital, Inc. committed since its inception?

Since its inception in December 2003, Hercules Capital has committed over $4.6 billion to more than 300 companies.

What kind of financial products does Hercules Capital, Inc. offer?

Hercules Capital offers a mix of structured debt with warrants, senior debt, and equity investments.

Can you provide an example of a recent investment by Hercules Capital, Inc.?

A recent investment by Hercules Capital includes a $35 million loan facility to SynOx Therapeutics Limited for developing emactuzumab.

Why do companies choose Hercules Capital, Inc.?

Companies choose Hercules Capital for its reliable growth capital, access to an extensive network of contacts, and valuable business advice.

How does Hercules Capital, Inc. support its portfolio companies beyond financial investment?

Beyond financial investment, Hercules Capital offers access to a wide network of contacts and essential business advice to help companies achieve key milestones.

What is a notable recent achievement of Hercules Capital, Inc.?

A notable recent achievement is the $150 million financing to Harness to support the expansion of their software delivery platform.

How does Hercules Capital, Inc. ensure its financial stability?

Hercules ensures financial stability through strategic partnerships, diversified investment portfolios, and deep industry expertise.

What is the significance of Hercules Capital, Inc. in the venture lending space?

Hercules Capital is a leading lender of choice for entrepreneurs and venture capital firms, highlighted by its extensive commitments and successful partnerships with high-growth companies.
Hercules Capital Inc

NYSE:HTGC

HTGC Rankings

HTGC Stock Data

3.76B
169.33M
1.76%
25.96%
3%
Asset Management
Financial Services
Link
United States
SAN MATEO